Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell

Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell

Transitional cell carcinoma (TCC) represents the most frequent type of bladder cancer. Recently, studies have focused on molecular tumor classifications in order to diagnose tumor subtypes and predict future clinical behavior. Increased expression of HER1 and HER2 receptors in TTC is related to adva...

Full description

Bibliographic Details
Main Authors: Julieti Huch Buss, Karine Rech Begnini, Franciele Aline Bruinsmann, Taíse Ceolin, Mariana Souza Sonego, Adriana Raffin Pohlmann, Sílvia Stanisçuaski Guterres, Tiago Collares, Fabiana Kömmling Seixas
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Oncology
Subjects:
bladder cancer
her-positive
epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitor
nanocapsules
lapatinib
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00203/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00203/full

Similar Items